Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ventana Medical Systems has commenced patent litigation against Australian company Vision BioSystems over algorithm technology.
Subscribe to our email newsletter
In its complaint, Ventana alleges that Vision's Bond X and maX OCR instruments infringe its patent for scheduling algorithms which enable optimal sequencing of multiple tests. The complaint seeks injunctive relief and damages.
Ventana had previously obtained a summary judgment of infringement of its dual bar code patent against the earlier generation of Bond instruments.
The suit was filed in US District Court in September 2006
In addition, Ventana's lawsuit alleging infringement of its patent by the current Bond OCR instruments remains pending, subject to the successful conclusion of an appeal recently heard by the Court of Appeals for the Federal Circuit.